Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration Project
IntroductionThe effectiveness of daily pre-exposure prophylaxis (PrEP) is well established. However, there has been increasing interest in non-daily dosing schedules among gay and bisexual men (GBM). This paper explores preferences for PrEP dosing schedules among GBM at baseline in the PRELUDE demon...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-12-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fpubh.2017.00341/full |
id |
doaj-7bac30b958204167bbfd6a9af49b02aa |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Stefanie J. Vaccher Christopher Gianacas David J. Templeton David J. Templeton Isobel M. Poynten Bridget G. Haire Catriona Ooi Catriona Ooi Rosalind Foster Rosalind Foster Anna McNulty Anna McNulty Andrew E. Grulich Iryna B. Zablotska On Behalf of the PRELUDE Study Team Andrew Carr Andrew Grulich Anna McNulty Brent Mackie Cathy Pell Catriona Ooi Cheung (Yvonne) Ching Chris Gianacas David Templeton Dean Murphy Edwina Wright Garrett Prestage Isobel (Mary) Poynten John de Wit John Kaldor John McAllister Kenneth Mayer Mark Bloch Martin Holt Nathan Ryder Rebecca Guy Rosalind Foster Stefanie Vaccher |
spellingShingle |
Stefanie J. Vaccher Christopher Gianacas David J. Templeton David J. Templeton Isobel M. Poynten Bridget G. Haire Catriona Ooi Catriona Ooi Rosalind Foster Rosalind Foster Anna McNulty Anna McNulty Andrew E. Grulich Iryna B. Zablotska On Behalf of the PRELUDE Study Team Andrew Carr Andrew Grulich Anna McNulty Brent Mackie Cathy Pell Catriona Ooi Cheung (Yvonne) Ching Chris Gianacas David Templeton Dean Murphy Edwina Wright Garrett Prestage Isobel (Mary) Poynten John de Wit John Kaldor John McAllister Kenneth Mayer Mark Bloch Martin Holt Nathan Ryder Rebecca Guy Rosalind Foster Stefanie Vaccher Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration Project Frontiers in Public Health pre-exposure prophylaxis non-daily dosing event-driven pre-exposure prophylaxis periodic pre-exposure prophylaxis HIV gay and bisexual men |
author_facet |
Stefanie J. Vaccher Christopher Gianacas David J. Templeton David J. Templeton Isobel M. Poynten Bridget G. Haire Catriona Ooi Catriona Ooi Rosalind Foster Rosalind Foster Anna McNulty Anna McNulty Andrew E. Grulich Iryna B. Zablotska On Behalf of the PRELUDE Study Team Andrew Carr Andrew Grulich Anna McNulty Brent Mackie Cathy Pell Catriona Ooi Cheung (Yvonne) Ching Chris Gianacas David Templeton Dean Murphy Edwina Wright Garrett Prestage Isobel (Mary) Poynten John de Wit John Kaldor John McAllister Kenneth Mayer Mark Bloch Martin Holt Nathan Ryder Rebecca Guy Rosalind Foster Stefanie Vaccher |
author_sort |
Stefanie J. Vaccher |
title |
Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration Project |
title_short |
Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration Project |
title_full |
Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration Project |
title_fullStr |
Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration Project |
title_full_unstemmed |
Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration Project |
title_sort |
baseline preferences for daily, event-driven, or periodic hiv pre-exposure prophylaxis among gay and bisexual men in the prelude demonstration project |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Public Health |
issn |
2296-2565 |
publishDate |
2017-12-01 |
description |
IntroductionThe effectiveness of daily pre-exposure prophylaxis (PrEP) is well established. However, there has been increasing interest in non-daily dosing schedules among gay and bisexual men (GBM). This paper explores preferences for PrEP dosing schedules among GBM at baseline in the PRELUDE demonstration project.Materials and methodsIndividuals at high-risk of HIV were enrolled in a free PrEP demonstration project in New South Wales, Australia, between November 2014 and April 2016. At baseline, they completed an online survey containing detailed behavioural, demographic, and attitudinal questions, including their ideal way to take PrEP: daily (one pill taken every day), event-driven (pills taken only around specific risk events), or periodic (daily dosing during periods of increased risk).ResultsOverall, 315 GBM (98% of study sample) provided a preferred PrEP dosing schedule at baseline. One-third of GBM expressed a preference for non-daily PrEP dosing: 20% for event-driven PrEP, and 14% for periodic PrEP. Individuals with a trade/vocational qualification were more likely to prefer periodic to daily PrEP [adjusted odds ratio (aOR) = 4.58, 95% confidence intervals (95% CI): (1.68, 12.49)], compared to individuals whose highest level of education was high school. Having an HIV-positive main regular partner was associated with strong preference for daily, compared to event-driven PrEP [aOR = 0.20, 95% CI: (0.04, 0.87)]. Participants who rated themselves better at taking medications were more likely to prefer daily over periodic PrEP [aOR = 0.39, 95% CI: (0.20, 0.76)].DiscussionIndividuals’ preferences for PrEP schedules are associated with demographic and behavioural factors that may impact on their ability to access health services and information about PrEP and patterns of HIV risk. At the time of data collection, there were limited data available about the efficacy of non-daily PrEP schedules, and clinicians only recommended daily PrEP to study participants. Further research investigating how behaviours and PrEP preferences change correspondingly over time is needed.Trial registrationClinicalTrials.gov NCT02206555. Registered 28 July 2014. |
topic |
pre-exposure prophylaxis non-daily dosing event-driven pre-exposure prophylaxis periodic pre-exposure prophylaxis HIV gay and bisexual men |
url |
http://journal.frontiersin.org/article/10.3389/fpubh.2017.00341/full |
work_keys_str_mv |
AT stefaniejvaccher baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT christophergianacas baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT davidjtempleton baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT davidjtempleton baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT isobelmpoynten baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT bridgetghaire baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT catrionaooi baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT catrionaooi baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT rosalindfoster baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT rosalindfoster baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT annamcnulty baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT annamcnulty baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT andrewegrulich baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT irynabzablotska baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT onbehalfofthepreludestudyteam baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT andrewcarr baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT andrewgrulich baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT annamcnulty baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT brentmackie baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT cathypell baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT catrionaooi baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT cheungyvonneching baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT chrisgianacas baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT davidtempleton baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT deanmurphy baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT edwinawright baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT garrettprestage baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT isobelmarypoynten baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT johndewit baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT johnkaldor baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT johnmcallister baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT kennethmayer baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT markbloch baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT martinholt baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT nathanryder baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT rebeccaguy baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT rosalindfoster baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject AT stefanievaccher baselinepreferencesfordailyeventdrivenorperiodichivpreexposureprophylaxisamonggayandbisexualmeninthepreludedemonstrationproject |
_version_ |
1725437563923070976 |
spelling |
doaj-7bac30b958204167bbfd6a9af49b02aa2020-11-25T00:02:29ZengFrontiers Media S.A.Frontiers in Public Health2296-25652017-12-01510.3389/fpubh.2017.00341317405Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration ProjectStefanie J. Vaccher0Christopher Gianacas1David J. Templeton2David J. Templeton3Isobel M. Poynten4Bridget G. Haire5Catriona Ooi6Catriona Ooi7Rosalind Foster8Rosalind Foster9Anna McNulty10Anna McNulty11Andrew E. Grulich12Iryna B. Zablotska13On Behalf of the PRELUDE Study TeamAndrew CarrAndrew GrulichAnna McNultyBrent MackieCathy PellCatriona OoiCheung (Yvonne) ChingChris GianacasDavid TempletonDean MurphyEdwina WrightGarrett PrestageIsobel (Mary) PoyntenJohn de WitJohn KaldorJohn McAllisterKenneth MayerMark BlochMartin HoltNathan RyderRebecca GuyRosalind FosterStefanie VaccherThe Kirby Institute, UNSW Sydney, Sydney, NSW, AustraliaThe Kirby Institute, UNSW Sydney, Sydney, NSW, AustraliaThe Kirby Institute, UNSW Sydney, Sydney, NSW, AustraliaRPA Sexual Health, Sydney Local Health District and Central Clinical School, The University of Sydney, Sydney, NSW, AustraliaThe Kirby Institute, UNSW Sydney, Sydney, NSW, AustraliaThe Kirby Institute, UNSW Sydney, Sydney, NSW, AustraliaWestern Sydney Sexual Health Centre, Western Sydney Local Health District, Parramatta, NSW, AustraliaCentre for Infectious Diseases and Microbiology, Westmead Clinical School, University of Sydney, Sydney, NSW, AustraliaThe Kirby Institute, UNSW Sydney, Sydney, NSW, AustraliaClinic 16 Northern Sydney Sexual Health, Royal North Shore Community Health Centre, St Leonards, NSW, AustraliaSydney Sexual Health Centre, Sydney, NSW, AustraliaSchool of Public Health and Community Medicine, UNSW Sydney, Sydney, NSW, AustraliaThe Kirby Institute, UNSW Sydney, Sydney, NSW, AustraliaThe Kirby Institute, UNSW Sydney, Sydney, NSW, AustraliaIntroductionThe effectiveness of daily pre-exposure prophylaxis (PrEP) is well established. However, there has been increasing interest in non-daily dosing schedules among gay and bisexual men (GBM). This paper explores preferences for PrEP dosing schedules among GBM at baseline in the PRELUDE demonstration project.Materials and methodsIndividuals at high-risk of HIV were enrolled in a free PrEP demonstration project in New South Wales, Australia, between November 2014 and April 2016. At baseline, they completed an online survey containing detailed behavioural, demographic, and attitudinal questions, including their ideal way to take PrEP: daily (one pill taken every day), event-driven (pills taken only around specific risk events), or periodic (daily dosing during periods of increased risk).ResultsOverall, 315 GBM (98% of study sample) provided a preferred PrEP dosing schedule at baseline. One-third of GBM expressed a preference for non-daily PrEP dosing: 20% for event-driven PrEP, and 14% for periodic PrEP. Individuals with a trade/vocational qualification were more likely to prefer periodic to daily PrEP [adjusted odds ratio (aOR) = 4.58, 95% confidence intervals (95% CI): (1.68, 12.49)], compared to individuals whose highest level of education was high school. Having an HIV-positive main regular partner was associated with strong preference for daily, compared to event-driven PrEP [aOR = 0.20, 95% CI: (0.04, 0.87)]. Participants who rated themselves better at taking medications were more likely to prefer daily over periodic PrEP [aOR = 0.39, 95% CI: (0.20, 0.76)].DiscussionIndividuals’ preferences for PrEP schedules are associated with demographic and behavioural factors that may impact on their ability to access health services and information about PrEP and patterns of HIV risk. At the time of data collection, there were limited data available about the efficacy of non-daily PrEP schedules, and clinicians only recommended daily PrEP to study participants. Further research investigating how behaviours and PrEP preferences change correspondingly over time is needed.Trial registrationClinicalTrials.gov NCT02206555. Registered 28 July 2014.http://journal.frontiersin.org/article/10.3389/fpubh.2017.00341/fullpre-exposure prophylaxisnon-daily dosingevent-driven pre-exposure prophylaxisperiodic pre-exposure prophylaxisHIVgay and bisexual men |